2004
DOI: 10.5414/cpp42063
|View full text |Cite
|
Sign up to set email alerts
|

Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD) – a review based on randomized, controlled studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2006
2006
2013
2013

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(15 citation statements)
references
References 0 publications
0
15
0
Order By: Relevance
“…Lactone acts as a PAF antagonist and improves blood rheology, modulates neurotransmitter release, increases oxygen and glucose supply of ischemic tissues and lowers blood viscosity. Two randomized, double-blind, placebo-controlled trials (Schneider et al, 2005;Horsch and Walther, 2004) proved that EGb could improve cognitive performance of patients with Alzheimer's disease and the outcome of patients with peripheral arterial occlusive disease. Zeybek et al(2003) found prophylactic application of EGb caused significant decrease in serum amylase and lipase levels compared with the control group.…”
Section: Ginkolide Bmentioning
confidence: 99%
“…Lactone acts as a PAF antagonist and improves blood rheology, modulates neurotransmitter release, increases oxygen and glucose supply of ischemic tissues and lowers blood viscosity. Two randomized, double-blind, placebo-controlled trials (Schneider et al, 2005;Horsch and Walther, 2004) proved that EGb could improve cognitive performance of patients with Alzheimer's disease and the outcome of patients with peripheral arterial occlusive disease. Zeybek et al(2003) found prophylactic application of EGb caused significant decrease in serum amylase and lipase levels compared with the control group.…”
Section: Ginkolide Bmentioning
confidence: 99%
“…There is a registered medicine on the market containing G. biloba , Tavonin®, which is used for patients that don't respond (enough) to walking exercise (16). In patients with claudicatio intermittens, a positive effect at a dose of 120 mg/day was seen in two meta-analyses (21, 22). However, a recent systematic review that included 739 patients from 14 trials (with different dosage and duration of treatment) didn't find a significant effect on walking distance in people with claudication intermittens (23).…”
Section: Resultsmentioning
confidence: 99%
“…On the other hand, histamine analogs have been associated with side effects, such as drowsiness and dry mouth, especially in elderly patients. Vasoactive effects have also been demonstrated for Ginkgo biloba extracts, which cause vasorelaxation in precontracted isolated rat thoracic aortic rings by stimulation of endothelial NO production [19] and exert considerable therapeutic effects in patients with peripheral arterial occlusive disease [11].…”
Section: Discussionmentioning
confidence: 98%